Promoting safe and ethical clinical trials
The MRCT Center is a research and policy center associated with two of the world’s most respected names in healthcare and academia: Brigham and Women’s Hospital and Harvard University. Our multidisciplinary teams collaborate to identify challenges and deliver ethical, actionable, and practical solutions for the global clinical trial enterprise, with a focus on emerging economies. Our efforts have resulted in the implementation of improved clinical research practices, greater transparency, clearer communication, increased diversity and inclusion, and improved safety for research participants. We function as an independent convening group to bring together collaborative multidisciplinary teams to identify expert stakeholders from industry, academia, advocacy groups, nonprofit organizations, and regulatory agencies to address critical issues in the conduct and oversight of clinical trials. We engage patients and participants throughout all stages of our work.
Improve the integrity, safety, and rigor of global clinical trials
Engage diverse stakeholders to define emerging issues in global clinical trials and to create and implement ethical, actionable, and practical solutions.
We strive to:
- Identify regulatory, oversight, and ethics issues and facilitate solutions in clinical trials around the world
- Resolve regulatory and ethical issues in order to improve the clinical trial enterprise
- Foster respect for clinical trial participants by working to improve the ethics, safety and transparency of clinical trials
- Promote regulatory convergence within multiple regions to accelerate innovation and improve health care around the world
Long-term solutions to problems arising from the globalization of clinical research will require input from multidisciplinary stakeholders around the world. The future of academic clinical trials and of the pharmaceutical, biotechnology, and device industries is predicated on addressing these issues.